Latest filing published 20 Mar 2018 for Atara Biotherapeutics, Inc., €103k.
Filing timeline
BuySaleInsider track record
John Mcgrath: trading record in brief
This profile gathers the share dealings of John Mcgrath across 3 companies, led by Atara Biotherapeutics, Inc., Network Equipment Technologies Inc and Endwave Corp. We count 87 filings; the first trade dates from 5 May 2006 and the latest from 20 March 2018.
Every open-market trade on record is a sale: 31 sales worth €5.0M. Besides market trades, the filings include 13 share grants and 26 option exercises. In 2018 alone, the filings show no purchases and 9 sales.
Most recently, on 20 March 2018, the filings show an open-market sale worth €94k in Atara Biotherapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to John Mcgrath
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,000 shares@ US$41.992.6% of flowCommon StockSEC:0001209191-18-020971:0
- 3,000 shares@ US$38.832.4% of flowCommon StockSEC:0001209191-18-020971:1
- 5,132 shares0Common StockSEC:0001209191-18-011664:1
- 6,500 shares@ US$46.776.2% of flowCommon StockSEC:0001209191-18-011664:0
- 2,926 shares@ US$47.052.8% of flowCommon StockSEC:0001209191-18-011664:2
- 4,000 shares@ US$46.933.8% of flowCommon StockSEC:0001209191-18-011664:3
- 2,500 shares@ US$48.082.4% of flowCommon StockSEC:0001209191-18-011664:4
- 4,819 shares@ US$41.704.2% of flowCommon StockSEC:0001209191-18-009405:0
- 25,000 shares0Common StockSEC:0001209191-18-008508:0
- 4,279 shares@ US$35.803.2% of flowCommon StockSEC:0001209191-18-008508:1
- 3,500 shares@ US$20.771.5% of flowCommon StockSEC:0001209191-18-003485:0
- 30,000 shares@ US$11.007.0% of flowCommon StockSEC:0001209191-18-003485:1
- 3,500 shares@ US$22.321.7% of flowCommon StockSEC:0001209191-18-003485:2
- 30,000 shares@ US$25.0015.9% of flowCommon StockSEC:0001209191-18-003485:3
- 32,000 shares@ US$20.0013.6% of flowCommon StockSEC:0001209191-18-000376:0
- 7,697 shares0Common StockSEC:0001209191-17-061602:0
- 2,100 shares@ US$14.230.6% of flowCommon StockSEC:0001209191-17-049449:1
- 2,100 shares@ US$14.390.7% of flowCommon StockSEC:0001209191-17-049449:2
- 7,697 shares0Common StockSEC:0001209191-17-049449:0
- 2,000 shares@ US$14.950.7% of flowCommon StockSEC:0001209191-17-033208:2
- 2,000 shares@ US$15.270.7% of flowCommon StockSEC:0001209191-17-033208:3
- 935 shares0Common StockSEC:0001209191-17-033208:0
- 7,698 shares0Common StockSEC:0001209191-17-033208:1
- 7,500 shares@ US$20.273.6% of flowCommon StockSEC:0001209191-17-022684:0
- 6,500 shares@ US$21.083.2% of flowCommon StockSEC:0001209191-17-022684:1
25 of 85 declarations
